Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-06

FDA Approved: ULTRA SLEEP AID — Supplemental Application (Walgreen Company)

View source ↗

Summary

FDA approved a supplemental application for ULTRA SLEEP AID containing doxylamine succinate from Walgreens Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ULTRA SLEEP AID (Doxylamine succinate)

Snippet

SUPPL AP for ULTRA SLEEP AID (DOXYLAMINE SUCCINATE)